1-3417951-C-G
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_022114.4(PRDM16):āc.2815C>Gā(p.Leu939Val) variant causes a missense change. The variant allele was found at a frequency of 0.000184 in 1,613,180 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L939I) has been classified as Likely benign.
Frequency
Consequence
NM_022114.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
PRDM16 | NM_022114.4 | c.2815C>G | p.Leu939Val | missense_variant | 11/17 | ENST00000270722.10 | |
PRDM16 | NM_199454.3 | c.2815C>G | p.Leu939Val | missense_variant | 11/17 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
PRDM16 | ENST00000270722.10 | c.2815C>G | p.Leu939Val | missense_variant | 11/17 | 1 | NM_022114.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000151 AC: 23AN: 152208Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000597 AC: 147AN: 246430Hom.: 0 AF XY: 0.000552 AC XY: 74AN XY: 134164
GnomAD4 exome AF: 0.000188 AC: 274AN: 1460854Hom.: 1 Cov.: 36 AF XY: 0.000184 AC XY: 134AN XY: 726710
GnomAD4 genome AF: 0.000151 AC: 23AN: 152326Hom.: 0 Cov.: 33 AF XY: 0.000175 AC XY: 13AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, flagged submission | clinical testing | GeneDx | Dec 14, 2016 | A variant of uncertain significance has been identified in the PRDM16 gene. The L939V variant has not been published as a pathogenic variant or been reported as a benign variant to our knowledge. Although the L939V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties, it occurs at a position that is conserved across species. Furthermore, in silico analysis predicts this variant may be damaging to the protein structure/function. Nevertheless, ExAC reports L939V was observed in approximately 0.8% of alleles from individuals of East Asian ancestry, indicating it may be a rare benign variant in this population.Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or a rare benign variant in individuals of Asian ancestry. This result cannot be interpreted for diagnosis or used for family member screening at this time. - |
Microcephaly Uncertain:1
Uncertain significance, no assertion criteria provided | research | Department of Pediatrics, Samsung Medical Center, Samsung Medical Center | - | - - |
PRDM16-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 12, 2021 | - - |
Left ventricular noncompaction 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 09, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at